Kevin Shaw, MD

Kevin Shaw, MD

General Pulmonary, Critical Care

Dr. Shaw was named a “Top Doc” in San Diego Magazine’s “Physicians of Exceptional Excellence” annual survey performed in collaboration with the San Diego County Medical Society 2012, 2013, 2015 and 2016.

Dr. Shaw’s specialties include flexible bronchoscopy, pleural diseases, ECMO, bronchiectasis, and all critical care procedures.

Degrees and Education

  • University of California San Diego, Bachelor of Science, Molecular Biology 1996-1999
  • University of California San Diego School of Medicine Doctor of Medicine 2000-2004

Postdoctoral Training

  • Internship in Internal Medicine, University of Utah, Salt Lake City, UT 2004-2005
  • Residency in Internal Medicine, University of Utah, Salt Lake City, UT 2005-2007
  • Fellowship in Pulmonary and Critical Care Medicine, University of California San Diego 2007-2010

Positions

  • Pulmonary/Critical Care, Sharp Healthcare 2015-Present
  • Medical Director, Sharp Coronado Intensive Care Unit 2016
  • Associate Clinical Professor of Medicine, UCSD 2010-2016
  • Associate Director, UCSD Adult Cystic Fibrosis Clinic 2010-2015
  • Medical Director, UCSD Pulmonary Procedures 2011-2013
  • Associate Director, UCSD Fellowship Training Program Division of Pulmonary and Critical Care Medicine 2012-2015

Affiliations

  • Sharp Coronado Hospital 250 Prospect Pl Coronado, CA 92118, 2016-Present
  • Sharp Memorial Hospital 7901 Frost St. San Diego, CA 92123, 2015-Present

Educational Service

  • Instructor, Physical Exam Course University of Utah School of Medicine
  • Instructor, Phlebotomy Course UCSD School of Medicine
  • Instructor, Introduction to Clinical Medicine UCSD School of Medicine
  • Organizer and Instructor Pulmonary and Critical Care Fellowship Cadaver Lab
  • Speaker and Instructor, UCSD Residents’ Conference Critical Care Medicine Board Review
  • Speaker and Instructor, UCSD Residents’ Conference Principles of Thoracentesis
  • Instructor, Objective Structured Clinical Examination UCSD School of Medicine
  • Speaker and Instructor, UCSD Residents’ Conference Ultrasound-Guided Central Line Placement
  • Speaker and Instructor, UCSD Residents’ Conference Introduction to Mechanical Ventilation
  • Speaker and Instructor, UCSD Residents’ Conference Introduction to Bronchiectasis
  • Speaker and Instructor, UCSD Residents’ Conference Cystic Fibrosis Guide to Management
  • Instructor, Problem Based Learning Small Group UCSD School of Medicine
  • Faculty Reviewer UCSD Critical Care Nursing Education Conference
  • Instructor, Pulmonary Systems II Curriculum UCSD School of Medicine
  • Faculty Discussant, GI Fellows’ Conference Gastrointestinal Effects of Cystic Fibrosis
  • Faculty Consultant UCSD Pharmacy Ground Rounds Presentation
  • Speaker and Instructor, Medicine R2 Transition Day Ultrasound-Guided Central Line Placement
  • Speaker and Instructor, PCCM Fellowship Orientation Ultrasound-Guided Central Line Placement
  • Clinical Director, Pulmonary Systems II Curriculum UCSD School of Medicine
  • Instructor, Clinical Correlation Conference UCSD School of Medicine
  • Director, Phlebotomy Course UCSD School of Medicine
  • Speaker and Instructor UCSD Undergraduate Medical Education Expo
  • Speaker and Instructor, Medicine Intern Orientation Ultrasound-Guided Central Line Placement
  • Speaker and Instructor Invasive Procedures for Hospitalists Seminar
  • Speaker and Faculty Reviewer UCSD ICU Case Study Investigation Conference
  • Speaker and Instructor, Scripps Mercy Residents’ Conference, Bronchiectasis
  • Speaker and Instructor, ICU Updates Course Sharp Memorial Hospital

Community Service

  • Mentor, UCSD Premedical Association of Students for Service
  • UCSD-Honduras Medical Education Partnership
  • Medical Student Volunteer, UCSD Student-Run Free Clinic
  • Medical Student Liaison, VIIDAI (http://www.viidai.com/) Viajes Interinstitucional de Integración Docente, Asistencial y de Investigación
  • Medical Director, Scripps Ranch Old Pros 4th of July Run & Ride
  • Speaker and Instructor, Southern California Asthma Medical Program
  • Medical Director, Scripps Ranch Community Association 40th Anniversary Run-Walk Event
  • Speaker and Instructor, St. Augustine High School Water Safety Course
  • CPR and AED Training to Scripps Ranch Community

Certifications

  • Advanced Cardiac Life Support Provider
  • National Board of Medical Examiners
  • Utah Physician and Surgeon License
  • Drug Enforcement Agency
  • California Physician and Surgeon License
  • American Board of Internal Medicine Internal Medicine
  • Fluoroscopy Supervisor and Operator License
  • American Board of Internal Medicine, Pulmonary Disease
  • American Board of Internal Medicine, Critical Care Medicine

Professional Memberships

  • Society of Critical Care Medicine
  • American Thoracic Society
  • American College of Chest Physicians
  • California Thoracic Society

todocs_logo_web

  • Top Doctor Award, San Diego County Medical Society 2012, 2013, 2015, 2016
  • Provost’s Honors Each Quarter University of California San Diego 1996-2000
  • Golden Key National Honor Society 1997
  • Phi Beta Kappa 1999
  • Honors at Graduation, Department of Biology University of California San Diego 2000
  • Magna Cum Laude, University of California San Diego 2000
  • Outstanding Intern of the Year, University of Utah Department of Internal Medicine 2005
  • Chief Residents’ Teaching Award, University of California San Diego 2011
  • Kaiser Excellence in Teaching Award Nominee 2012-2014
  • Scripps Ranch Civic Association Certificate of Appreciation for Community Medical Education 2013
  • Valedictorian, National Center of Leadership in Academic Medicine (NCLAM) 2013

Publications

  1. Mahmud E, Shaw KD, Penny WF. Patients at low risk for periprocedural myocardial infarction can be identified by assessment immediately following percutaneous coronary intervention. J Invasive Cardiol 15:343-7, 2003
  2. Shaw KD. Pulmonary Function Tests in Clinical Decision Support: Hospital Medicine, edited by Wiese J, Auerbach A, Glasheen J, Li K. Decision Support in Medicine, LLC. Wilmington, DE; 2012.
  3. Shaw KD, Johnson MB, Chang W. Thoracentesis in Clinical Decision Support: Hospital Medicine, edited by Wiese J, Auerbach A, Glasheen J, Li K. Decision Support in Medicine, LLC. Wilmington, DE; 2012.
  4. Shaw KD. Bronchiectasis in Manual of Clinical Problems in Pulmonary Medicine, edited by Morris TA, Ries AL, Bordow RA. Lippincott Williams & Wilkins; 2014.

 

Presentations

  1. American College of Physicians Utah Chapter, Clinical Vignette Competition 2006, Runner-Up. An Unusual Insulinoma Case.
  2. American Thoracic Society International Conference 2009. A Novel Assay to Investigate Ion Transport Across Mouse Airway Epithelium.
  3. North American Cystic Fibrosis Conference 2009. Evidence of ΔF508 CFTR Activity in the Intact Native Lower Airways of the CF Mouse.
  4. UCSD Summer Critical Care Conference 2010. Advanced Modes of Ventilation.
  5. California Thoracic Society 2011. 75 y.o. Female with Dry Cough.
  6. Rady Children’s Hospital Cystic Fibrosis Family Education Day 2012. Transition to the Adult Clinic.
  7. Topics & Advances in Pulmonary and Critical Care Medicine 2013. Ultrasound-Guided Central Line Placement, Hands-on Simulation Session.
  8. Rady Children’s Hospital Bioethics Education Program 2013. A Transition Too Late: Efforts at the End of Life.
  9. American Thoracic Society Resident Boot Camp 2014. Airway Management 101.
  10. UCSD Heart/Lung Transplant Conference 2014. Cystic Fibrosis and Lung Transplant.
  11. Rady Children’s Hospital Cystic Fibrosis Staff Education Day 2014. Cystic Fibrosis and Transition.
  • Laboratory Technician, 1997-1999, University of California San Diego. Principal Investigator Jeffrey Esko, Ph.D. Assisted with multiple research projects, with responsibilities including screening a cDNA library, cloning, sequencing, plasmid construction, and initiation of a yeast 2-hybrid system to investigate Golgi apparatus protein interactions.
  • Research Fellow in Pulmonary and Critical Care Medicine, 2008-2010, University of California San Diego. Principal Investigator Paul Quinton, Ph.D. Our project included determination of electrolyte transport properties in the intact lower murine airways. We developed a novel assay which uses perfused ex-vivo murine lungs, in an attempt to better replicate in-vivo conditions than is possible with cell culture models. Specific topics of investigation included the roles of CFTR and the calcium-activated chloride channel, comparing both wild type and ΔF508 cystic fibrosis mice.
  • A Phase 3, International, Multi-Center, Randomized, Double-Blind, Placebo- Controlled, Parallel-Group Efficacy and Safety Study of Denufosol Tetrasodium Inhalation Solution in Patients with Cystic Fibrosis Lung Disease and FEV1 greater than or equal to 75% but less than or equal to 110% Predicted TIGER-2 (Inspire 08-110) Amendment 1 / Co-PI HRPP #081213 Closed 4/25/11
  • Protocol Title: Study 08-114: Open-label Extension of Study 08-110, A Multi- Center Study of Denufosol Tetrasodium Inhalation Solution in Patients with Cystic Fibrosis Lung Disease Amendment: January 20, 2010 (Inspire Tiger 2 Open Label Study) / Co-PI HRPP #101101 Closed 5/5/11
  • Clofazimine for single patient use. / PI HRPP #101879 Closed 8/12/11
  • A Phase 3 Efficacy and Safety Study of PTC124 as an Oral Treatment for Nonsense-Mutation-Mediated Cystic Fibrosis PTC-124-GD-009-CF; Protocol Version 2 / Co-PI HRPP #091065 Closed 4/10/12
  • A Phase 3, Open-Label, Randomized Trial to Evaluate the Safety and Efficacy of MP-376 Inhalation Solution (AeroquinTM) Versus Tobramycin Inhalation Solution (TIS) in Stable Cystic Fibrosis; Study Number: MPEX-209 / PI HRPP #110852
  • A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Placebo- Controlled Study to Evaluate the Efficacy and Safety of MP-376 (Levofloxacin Inhalation Solution; AeroquinTM) in Stable Cystic Fibrosis Patients; Study Number: MPEX 207 / Co-PI HRPP #110431
  • A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy (CAT) Regimen of Inhaled Antibiotics for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Subjects with Cystic Fibrosis; Study Number: GS-US-205-0170 / PI HRPP #121356
  • A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients with Cystic Fibrosis Treated with Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors; Study Number: CFFC-OB-11 / PI HRPP #121086
  • A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination with Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation; Study Number: VX12-809-103 / Sub-PI HRPP #130404
  • A Phase 2, Multicenter, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Lumacaftor Monotherapy, and Lumacaftor and Ivacaftor Combination Therapy in Subjects With Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation; Study Number: VX12-809-102 / PI HRPP #131206
  • A Phase 3, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation; Study Number: VX12-809-105 / Sub-PI HRPP #131505

Grant Support:

  • Cystic Fibrosis Foundation 3rd Year Clinical Fellowship 2009-2010
  • Cystic Fibrosis Foundation Program for Adult Care Excellence (PACE) Award 2010-2013
  • UC San Diego Academy of Clinical Scholars Faculty Development Award 2013-2014